|
LMLN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21699991698188E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20348175869367E-13 |
| Normal-vs-Stage2 |
1.3523999999876E-06 |
| Normal-vs-Stage3 |
6.81421585824182E-12 |
| Normal-vs-Stage4 |
6.7090000221981E-11 |
| Stage1-vs-Stage2 |
3.254000E-01 |
| Stage1-vs-Stage3 |
2.378100E-02 |
| Stage1-vs-Stage4 |
8.739700E-02 |
| Stage2-vs-Stage3 |
8.281000E-03 |
| Stage2-vs-Stage4 |
1.941940E-02 |
| Stage3-vs-Stage4 |
9.882600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76699987974871E-10 |
| Normal-vs-AfricanAmerican |
4.3604999999669E-06 |
| Normal-vs-Asian |
5.08080000294342E-09 |
| Caucasian-vs-AfricanAmerican |
9.623200E-01 |
| Caucasian-vs-Asian |
8.671600E-01 |
| AfricanAmerican-vs-Asian |
8.789400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.23999954538112E-10 |
| Normal-vs-Female |
2.91839996613419E-10 |
| Male-vs-Female |
8.020200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.96369986516754E-10 |
| Normal-vs-Age(41-60Yrs) |
6.09623462821673E-13 |
| Normal-vs-Age(61-80Yrs) |
4.52049953025835E-10 |
| Normal-vs-Age(81-100Yrs) |
6.843700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.954200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.245600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.218400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.988800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.525400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.016400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.72689999999864E-05 |
| Classical-VS-Follicular |
6.601600E-02 |
| Classical-VS-Other |
5.784800E-01 |
| Classical-VS-Normal |
1.56589996525014E-09 |
| Tall-VS-Follicular |
1.28219999995238E-06 |
| Tall-VS-Other |
1.547970E-01 |
| Tall-VS-Normal |
1.69064762189919E-12 |
| Follicular-VS-Other |
3.072800E-01 |
| Follicular-VS-Normal |
1.55830000003743E-06 |
| Other-VS-Normal |
2.978600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.36886115962443E-13 |
| Normal-vs-N1 |
1.40180000940404E-09 |
| N0-vs-N1 |
3.351200E-01 |
|
|
